Skip to main content
. 2021 Sep 25;19:97. doi: 10.1186/s12964-021-00743-w

Fig. 4.

Fig. 4

Inhibition of BMPR2 activates lysosomes in sensitive lung cancer cell lines but not in MDA-MB-468 cells. A Immunofluorescence imaging of LAMP1 in treated A549 cells treated with JL5. (B-C) Immunofluorescence imaging for Lysotracker™ Green and Green Cathepsin B of A549 treated with JL5 for 24 h. D Immunofluorescence imaging of Lysotracker™ Green of H1299 treated with JL5. E Immunofluorescence imaging for LAMP1 and Lysotracker™ Green of cells treated with DMH1 for 24 h. FG Immunofluorescence imaging for Lysotracker™ Green and Green Cathepsin B of A549 cells transfected with control or BMPR2 siRNA for 48 h. H, I Immunofluorescence imaging for Lysotracker™ Green and LAMP1 of MDA-MB-468 cells treated for 24 h with JL5. (J-K) Immunofluorescence imaging Lysotracker™ Green of H1299 and MDA-MD-468 cells treated with Ym155 for 24 h. Each scale bar represents 10 μM